Are There Developmental Changes in Platelet Function for Children?

Discussion While most people realize that each stage of a child’s life is different, there are some areas that people do not realize are different. For example, there are many laboratory values which are different based on the age because there are developmental changes. Within the hematopoietic system there are many developmental changes that are common such as hemoglobin and hematocrit. Others are less well known such as children have quantitatively less fibrinogen, but the activity is the same as adult fibrinogen. Platelets are an important part of both the primary and secondary hemostasis processes. They develop from megakaryocytes in the bone marrow, and circulate in the blood with a lifespan of 7-10 days. “Following a vascular injury, platelets are activated by collagen exposed from the endothelium and engagement with von Willebrand factor (vWF), and this initiates subsequent formation of the hemostatic plug.” More platelets arrive at the vascular injury and they are cross-linked by fibrin to stabilize the plug. There are many tests that can be done to evaluate platelet function including platelet function analysis-100/200 which is one of the standards for assessment ofprimary hemostasis in children, thromboelastrometry, flow cytometry, platelet ELISA assay and others. Learning Point Developmental changes for platelets in children includes: Platelet count Around 22 weeks gestation, the fetal platelet count reaches adult levels. Preterm infants have p...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news

Related Links:

Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
AbstractBackgroundDieulafoy ’s lesion (DL) is a rare but increasingly recognized cause of severe upper GI hemorrhage (SUGIH). There is little consensus regarding the endoscopic approach to management of bleeding from DL.AimsOur purposes were to compare 30-day outcomes of patients with SUGIH from DL with Doppler endoscopic probe (DEP) monitoring of blood flow and guided treatment versus standard visually guided hemostasis (VG).MethodsEighty-two consecutive DL patients with SUGIH were identified in a large CURE Hemostasis database from previous prospective cohort studies and two recent RCTs at two university-based medi...
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Malignant hyperthermia (MH) and exertional rhabdomyolysis (ERM) have long been considered as episodic phenotypes occurring in healthy individuals with RYR1 mutations in response to external triggers. Recent studies have shown evidence for continuous neuromuscular and multisystem features in these patients. There is a histopathological overlap with MH/ERM and myopathies, and patients with MH-associated RYR1 mutations can present with prominent axial weakness later in life. Animal studies have shown bleeding disorders and an immunological gain of function due to MH/ERM related RYR1 mutations.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
We aim to describe clinical characteristics of patients with mitochondrial diseases admitted to intensive care unit, and investigate the factors related to mortality and clinical outcome. We retrospectively studied 16 pediatric patients with mitochondrial diseases resulting in 34 ICU admissions from Jan 2007 to Jan 2017. Demographics, clinical characteristics during ICU admission and prediction of mortality scores including PRISM-III and PIM 3 were obtained. Overall, 17 patients (9 males and 8 females) were admitted to ICU for 34 occasions due to respiratory difficulty (55.9%), sepsis (23.6%), status epilepticus (8.8%), po...
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
ConclusionRoxadustat was non-inferior to ESAs in maintaining hemoglobin levels in this cohort of patients with anemia of CKD on dialysis for at least 4  months who were previously treated with ESAs. Observed TEAEs were consistent with previous studies.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
AbstractObjectiveTo evaluate ferumoxytol-enhanced vascular suppression for visualizing branch nerves of the brachial plexus in magnetic resonance (MR) neurography.Materials and methodsSignal simulations were performed to determine ferumoxytol ’s effect on nerve-, fat-, and blood-to-muscle contrast and to optimize pulse sequence parameters. Prospective, in vivo assessment included 10 subjects with chronic anemia who underwent a total of 19 (9 bilateral) pre- and post-infusion brachial plexus exams using three-dimensional (3D), T2-weighted short-tau inversion recovery (T2-STIR) sequences at 3.0  T. Two musculoskel...
Source: Skeletal Radiology - Category: Radiology Source Type: research
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
ConclusionsAC appears safe and effective for the treatment of cirrhotic PVT; however, prospective studies to confirm these findings and evaluate additional outcomes are needed.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
AbstractBackgroundDieulafoy ’s lesion (DL) is a rare but increasingly recognized cause of severe upper GI hemorrhage (SUGIH). There is little consensus regarding the endoscopic approach to management of bleeding from DL.AimsOur purposes were to compare 30-day outcomes of patients with SUGIH from DL with Doppler endoscopic probe (DEP) monitoring of blood flow and guided treatment versus standard visually guided hemostasis (VG).MethodsEighty-two consecutive DL patients with SUGIH were identified in a large CURE Hemostasis database from previous prospective cohort studies and two recent RCTs at two university-based medi...
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research
More News: Anemia | Babies | Bleeding | Child Development | Children | Databases & Libraries | Education | Hematology | Jaundice | Laboratory Medicine | Learning | Pathology | Pediatrics | Perinatology & Neonatology | Phlebotomy | Students | Study | Thrombocytopenia | Universities & Medical Training | von Willebrand Disease